August 25, 2026 09:40 pm (IST)
Follow us:
Aurobindo Pharma receives USFDA approval for drug related to moderate dementia
Hyderabad/Mumbai, Mar 29 (IBNS) Aurobindo Pharma Limited, which manufactures generic pharmaceuticals and active pharmaceutical ingredients, announced on Tuesday that the company has received the final approval from the US Food & Drug Administration (USFDA) to manufacture and market Rivastigmine Tartrate Capsules USP, 1.5 mg, 3 mg, 4.5 mg and 6 mg.
This product is expected to be launched in the first quarter of fiscal year 2016-17.
The approved ANDA is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Exelon Capsules, 1.5 mg, 3 mg, 4.5 mg and 6 mg, of Novartis Pharmaceuticals Corporation, said the company.
Naproxen Sodium Tablets is used in the treatment of mild moderate dementia of the Alzheimer's and Parkinson's disease.
The approved product has an estimated market size of US$ 26.7 million for the twelve months ending January 2016 according to IMS.
This is the 67th ANDA (including 14 tentative approvals) to be approved out of Unit VII formulation facility in Hyderabad, India for manufacturing oral non-antibiotic products.
Aurobindo now has a total of 246 ANDA approvals (211 Final approvals including 10 from Aurolife Pharma LLC and 35 tentative approvals) from USFDA.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
RBI’s big forex boost: Banks mobilise $73 billion in just 11 weeks
Tue, Aug 25 2026
Tata Sierra.ev gets 5G superpowers as Tata Motors bets big on software-defined cars
Tue, Aug 25 2026
Bajaj Life Insurance launches ‘BSE 500 Momentum Value 50 Index Fund’ for ULIP customers. How to avail it?
Tue, Aug 25 2026
8 in 10 Digital Marketing Jobs in Mumbai Don't Ask for an MBA, Finds IIDE Review of 500 Job Descriptions
Tue, Aug 25 2026
How a minor bank account helps build savings habits early
Tue, Aug 25 2026
Sensex, Nifty slip in morning trade as metal stocks retreat; Shankesh Jewellers, Sunshine Pictures debut higher
Tue, Aug 25 2026
TCS, Porsche join forces in major AI move to transform mobility
Tue, Aug 25 2026